Veon Scientific

Executive Summary

Veon Scientific is a UK-based biotechnology company specializing in compact, open liquid handling automation platforms. Founded in 2016 and headquartered in London, the company addresses the limitations of traditional bulky, closed-system liquid handlers by offering developer-friendly, customizable instruments. Its flagship product, the i.prep 2, is a multi-channel liquid handler designed for easy integration into OEM systems, R&D labs, and custom workflows. By prioritizing openness and flexibility, Veon Scientific enables laboratories to build tailored automation solutions without vendor lock-in, targeting the growing demand for modular and interoperable lab equipment in diagnostics and digital health. The company is privately held and has not disclosed funding rounds or valuation, suggesting focus on organic growth and niche market penetration. With a strong emphasis on integration and developer experience, Veon Scientific positions itself as an enabler for companies seeking to automate liquid handling without sacrificing control or innovation. The company's compact form factor and compatability with diverse workflows position it well in the expanding liquid handling and laboratory automation market, valued at over $6 billion and growing at 7-9% annually. However, as a small, private entity, it faces challenges in scaling production, building brand recognition, and competing with larger established players like Hamilton, Tecan, and Beckman Coulter. Nonetheless, its differentiated strategy of openness and modularity could capture a dedicated customer base among integrators and specialized R&D teams.

Upcoming Catalysts (preview)

• Q3 2026Launch of Next-Generation i.prep Platform with Enhanced Throughput and Compatibility40% success
• Q4 2026Strategic OEM Partnership with Leading Diagnostics Company for Embedded Automation30% success